Hexadecylphosphocholine: a new and selective antitumor drug
about
Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in miceAffinity of alkylphosphocholines to biological membrane of prostate cancer: studies in natural and model systemsIn a trial of the use of miltefosine to treat HIV-related cryptosporidiosis in Zambian adults, extreme metabolic disturbances contribute to high mortality.Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strainMiltefosine--discovery of the antileishmanial activity of phospholipid derivatives.Synthesis and antifungal activities of miltefosine analogs.Antileishmanial structure-activity relationships of synthetic phospholipids: in vitro and in vivo activities of selected derivatives.Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica.Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp.On the mechanism of alkylphosphocholine (APC)-induced apoptosis in tumour cells.In vitro prediction of human intestinal absorption and blood-brain barrier partitioning: development of a lipid analog for micellar liquid chromatography.Interactions of alkylphosphocholines with model membranes-the Langmuir monolayer study.Synthesis of a phosphinate analogue of the anti-tumour phosphate di-ester perifosine via sequential radical processes.Toxicity study of erucylphosphocholine in a rat model.Mechanism of Action of Miltefosine on Leishmania donovani Involves the Impairment of Acidocalcisome Function and the Activation of the Sphingosine-Dependent Plasma Membrane Ca2+ Channel.Efficacy of miltefosine for topical treatment of Acanthamoeba keratitis in Syrian hamsters.In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis.
P2860
Q24671899-5C6E7BF3-64F1-4429-9759-59B1F17DC37DQ33735663-21C52A33-0A76-49A1-9B91-707FA031836FQ33854925-E363D750-7CC6-4CA9-8095-6F4BC3401D8DQ36365363-4A07A8AC-B47B-4848-907F-DE43A487412DQ36564101-95859746-70CF-4755-9F0D-F4219D684121Q37139795-F184831B-5811-4FBC-B7BA-8E45BE313F14Q39444305-D1C6A24C-010A-47B9-920D-0AF158A880F8Q39444318-CA271331-54F2-42D9-94C0-3E1A5B14C70FQ39653044-A8BCE0AF-964B-44A2-8FBB-E498E48C044FQ40432807-C55FAB9D-9BC0-4008-B527-1D734C9761A6Q40639437-7C0CC6AD-8356-447C-A3AA-32A8E8E19A4EQ41762814-F732FB11-0059-47AD-933A-F230659C1931Q45786112-7F5CF761-BE7B-497C-A890-1D251C707302Q46690910-EDC6D243-0DCB-4540-9EB2-54EFA81D24F1Q50072881-07F4A0F7-32F1-4A37-8D28-0703686901D7Q51766684-A67816CE-6049-45E4-8EBA-E15606902BFCQ55687565-E9CD9E12-8E00-484A-90B1-1E1DA3739249
P2860
Hexadecylphosphocholine: a new and selective antitumor drug
description
1990 nî lūn-bûn
@nan
1990 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Hexadecylphosphocholine: a new and selective antitumor drug
@ast
Hexadecylphosphocholine: a new and selective antitumor drug
@en
Hexadecylphosphocholine: a new and selective antitumor drug
@nl
type
label
Hexadecylphosphocholine: a new and selective antitumor drug
@ast
Hexadecylphosphocholine: a new and selective antitumor drug
@en
Hexadecylphosphocholine: a new and selective antitumor drug
@nl
prefLabel
Hexadecylphosphocholine: a new and selective antitumor drug
@ast
Hexadecylphosphocholine: a new and selective antitumor drug
@en
Hexadecylphosphocholine: a new and selective antitumor drug
@nl
P1476
Hexadecylphosphocholine: a new and selective antitumor drug
@en
P304
P356
10.1016/0305-7372(90)90053-I
P407
P577
1990-09-01T00:00:00Z